Protocol Number: AMGEN 20050103, Sponsor: Amgen, Inc.
 
  Eligibility

Criteria for participation:
  • Males 18 years of age or older with prostate cancer
  • On hormonal therapy
  • A rising PSA
  • No IV bisphosphonates
  • No active dental or jaw condition that requires surgery
  • No prior or current evidence of osteonecrosis/osteomyelitis of the jaw

Duration of Study
Study period will be 49 weeks during which time you will have weekly clinic visits for administration of study drug.

Qualified participants will receive study-related medical exams, laboratory tests, skeletal x-rays and study medication at no cost.

Clinical Research Coordinators:
Patricia Edwards, RN (336) 274-1114 ext. 5322
Karen Michael, RN (336) 274-1114 ext. 5328
E-mail address: research@allianceurology.com



Printable View